Immunic, Inc. to Participate in Investor Conferences in September

/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused...

Related Keywords

Boston ,Massachusetts ,United States ,Russia ,Ukraine ,Edna Kaplan ,Paula Schwartz ,Jessica Breu ,Daniel Vitt ,Exchange Commission ,Rx Communications Group ,Nasdaq ,Wells Fargo ,Immunic Inc ,Annual Biopharma ,Chief Executive Officer ,Investor Relations ,Annual Biopharma Conference ,Thalmann Healthcare ,Thalmann Healthcare Conference ,New York ,Private Securities Litigation Reform Act ,Annual Report ,Immunic ,Nc ,